Stockscreener 앱 받기
1.68
9.19%
-0.17
시간 외 거래:
1.69
0.01
+0.60%
전일 마감가:
$1.85
열려 있는:
$1.81
하루 거래량:
64,999
Relative Volume:
0.47
시가총액:
$3.65M
수익:
$10.48M
순이익/손실:
$-37.74M
주가수익비율:
-0.1038
EPS:
-16.1846
순현금흐름:
$-29.03M
1주 성능:
-18.45%
1개월 성능:
-23.29%
6개월 성능:
-87.06%
1년 성능:
-93.54%
1일 변동 폭
$1.66
$1.81
1주일 범위
$1.66
$2.09
52주 변동 폭
$1.5701
$33.25
재규어 헬스 Stock (JAGX) Company Profile
명칭
Jaguar Health Inc
전화
415-371-8300
주소
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
JAGX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
1.68 | 6.86M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
재규어 헬스 Stock (JAGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-07-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-07-11 | 개시 | Rodman & Renshaw | Buy |
재규어 헬스 주식(JAGX)의 최신 뉴스
How to use Fibonacci retracement on Jaguar Health Inc.Quarterly Performance Summary & Technical Buy Zone Confirmation - newser.com
Has Jaguar Health Inc. formed a bullish divergenceGap Down & Verified Stock Trade Ideas - newser.com
Short interest data insights for Jaguar Health Inc.CEO Change & Fast Momentum Stock Entry Tips - newser.com
Jaguar Health Inc. stock trendline breakdownEarnings Beat & High Conviction Buy Zone Picks - newser.com
Can you recover from losses in Jaguar Health Inc.July 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Waynesboro Record Herald
How hedge fund analytics apply to Jaguar Health Inc. stockQuarterly Profit Report & AI Powered Market Entry Ideas - newser.com
Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition - The Marion Star
News impact scoring models applied to Jaguar Health Inc.Market Activity Report & Smart Swing Trading Techniques - newser.com
Is Jaguar Health Inc. showing signs of accumulationQuarterly Market Summary & Community Consensus Trade Alerts - newser.com
Live market analysis of Jaguar Health Inc.Earnings Performance Report & Real-Time Chart Breakout Alerts - newser.com
Is Jaguar Health Inc. stock attractive for passive investorsJuly 2025 Volume & Growth Focused Stock Reports - newser.com
Will Jaguar Health Inc. benefit from macro trendsJuly 2025 News Drivers & Technical Analysis for Trade Confirmation - newser.com
Will Jaguar Health Inc. stock pay special dividendsWeekly Trade Analysis & Accurate Technical Buy Alerts - newser.com
How dovish Fed policy supports Jaguar Health Inc. (1JA0) stockJuly 2025 Setups & High Conviction Investment Ideas - newser.com
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts - Shelby Star
FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease - Lubbock Avalanche-Journal
Can Jaguar Health Inc. stock surprise with earnings upsideQuarterly Trade Summary & Weekly Sector Rotation Insights - newser.com
Published on: 2025-10-28 08:23:49 - fcp.pa.gov.br
재규어 헬스 (JAGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):